Bliss GVS Pharma Grants 3.2 Lakh Stock Options

Bliss GVS Pharma Limited has announced the outcome of its Nomination and Remuneration Committee meeting held on August 12, 2026. The committee granted 3,20,000 stock options under the Bliss GVS Pharma Limited – Employee Stock Options Plan 2019 to eligible employees. These options are convertible into equity shares of Re. 1/- face value each. The exercise price is set at ₹43 per option, determined by the BSE last closing market price on August 11, 2026, with a 91.32% discount applied for uniformity. The options will vest in four installments over 48 months, with a minimum one-year period between grant and vesting. The exercise period is six months from vesting, and vested shares will be subject to a six-month lock-in post-allotment.